Our team is dedicated to providing expert advice and personalized care, so reach out today to take the next step toward a healthy pregnancy
CQC Registration: In England, look for the CQC logo on their website or premises
Semaglutide and other drugs in its class have been life-changing for people living with obesity around the world
Endogenous GLP-1 affects postprandial blood glucose by slowing gastric emptying and glucose absorption in healthy subjects (Schirra et al., 2006)
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomized, open-label, phase 3b trial
May 15, 2025: Analysis Says People Taking Mounjaro Lose More Weight Than On Other GLP-1s A new analysis of post-clinical trial data has shown that people taking Mounjaro lose more weight than when taking most other GLP-1 drugs